| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.
|
J Acquir Immune Defic Syndr
|
2012
|
2.95
|
|
2
|
Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.
|
J Acquir Immune Defic Syndr
|
2010
|
2.25
|
|
3
|
HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual.
|
J Acquir Immune Defic Syndr
|
2002
|
1.97
|
|
4
|
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.
|
AIDS
|
2007
|
1.25
|
|
5
|
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.
|
PLoS Med
|
2012
|
1.15
|
|
6
|
Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study.
|
J Womens Health (Larchmt)
|
2011
|
1.15
|
|
7
|
C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s.
|
AIDS
|
2004
|
1.11
|
|
8
|
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.
|
AIDS
|
2011
|
1.10
|
|
9
|
Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count.
|
Antivir Ther
|
2011
|
1.02
|
|
10
|
Infant outcomes after maternal antiretroviral exposure in resource-limited settings.
|
Pediatrics
|
2012
|
1.02
|
|
11
|
HIV health care services for Mexican migrants.
|
J Acquir Immune Defic Syndr
|
2004
|
1.00
|
|
12
|
Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin.
|
Clin Pharmacol Ther
|
2003
|
0.96
|
|
13
|
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.
|
HIV Clin Trials
|
2011
|
0.89
|
|
14
|
Pregnancy rates and predictors in women with HIV/AIDS in Rio de Janeiro, Southeastern Brazil.
|
Rev Saude Publica
|
2011
|
0.84
|
|
15
|
Health-related quality of life in the gender, race, and clinical experience trial.
|
AIDS Res Treat
|
2011
|
0.83
|
|
16
|
Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE).
|
J Acquir Immune Defic Syndr
|
2014
|
0.80
|
|
17
|
Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals.
|
J Clin Immunol
|
2011
|
0.80
|
|
18
|
Current management challenges in HIV: tolerability of antiretrovirals and metabolic complications.
|
AIDS Patient Care STDS
|
2003
|
0.80
|
|
19
|
Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine.
|
AIDS
|
2014
|
0.79
|
|
20
|
Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey.
|
AIDS Patient Care STDS
|
2013
|
0.79
|
|
21
|
Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa.
|
BMC Infect Dis
|
2014
|
0.78
|
|
22
|
Report from the 14th Retrovirus Conference. Metabolic complications: lipoatrophy, lipohypertrophy, and cardiovascular risk.
|
AIDS Clin Care
|
2007
|
0.77
|
|
23
|
Cardiovascular risk factors and antiretroviral therapy.
|
N Engl J Med
|
2003
|
0.76
|
|
24
|
Report from the 11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV. Treatment for patients with central fat accumulation.
|
J Watch AIDS Clin Care
|
2010
|
0.75
|
|
25
|
Metabolic complications of HIV infection: translating research findings into clinical practice.
|
AIDS Clin Care
|
2002
|
0.75
|
|
26
|
Meeting report from the XV International AIDS Conference. Metabolic complications.
|
AIDS Clin Care
|
2004
|
0.75
|
|
27
|
Report from the 13th retrovirus conference. Metabolic complications and cardiovascular disease.
|
AIDS Clin Care
|
2006
|
0.75
|
|
28
|
Report from the 7th International Lipodystrophy Meeting.
|
AIDS Clin Care
|
2006
|
0.75
|
|
29
|
Report from the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.
|
AIDS Clin Care
|
2007
|
0.75
|
|
30
|
Report on the XIV International AIDS Conference.
|
AIDS Clin Care
|
2002
|
0.75
|
|
31
|
Top stories of 2004. HAART and the heart.
|
AIDS Clin Care
|
2005
|
0.75
|
|
32
|
Report from the Tenth Retrovirus Conference. Metabolic complications.
|
AIDS Clin Care
|
2003
|
0.75
|
|
33
|
Report from the 11th conference on retroviruses and opportunistic infections. Metabolic complications.
|
AIDS Clin Care
|
2004
|
0.75
|
|
34
|
Meeting notes from the 3rd IAS Conference. HIV treatment and risk for metabolic complications.
|
AIDS Clin Care
|
2005
|
0.75
|
|
35
|
Report from the 11th conference on retroviruses and opportunistic infections. Neurology of HIV.
|
AIDS Clin Care
|
2004
|
0.75
|